Table 1.
Clinical features of NSCLC patients
| Items | NSCLC patients (N = 381) |
|---|---|
| Age (years), mean±SD | 61.0 ± 10.3 |
| Gender (male/female), No. | 286/95 |
| History of smoke, No. (%) | 208 (54.6) |
| History of drink, No. (%) | 150 (39.4) |
| Common complications, No. (%) | |
| Hypertension | 146 (38.3) |
| Hyperlipidemia | 120 (31.5) |
| Diabetes | 62 (16.3) |
| Differentiation, No. (%) | |
| Well | 56 (14.7) |
| Moderate | 228 (59.8) |
| Poor | 97 (25.5) |
| Tumor size (cm), mean±SD | 5.2 ± 2.1 |
| LYN metastasis, No. (%) | 134 (35.2) |
| TNM stage, No. (%) | |
| I | 131 (34.4) |
| II | 107 (28.1) |
| III | 143 (37.5) |
| CEA (ng/mL), median (IQR) | 6.6 (3.2–27.1) |
NSCLC non-small cell lung carcinoma; SD standard deviation; LYN lymph node; CEA carcinoembryonic antigen; IQR interquartile range